{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:13:37Z","timestamp":1790140417909,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.dsx.2024.102992","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:13:43Z","timestamp":1711512823000},"page":"102992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of type 2 diabetes on cardiac arrhythmias in patients with obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"18","author":[{"given":"Shengwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2024.102992_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/2047487317709554","article-title":"Diabetes: prevalence, prognosis and management of a potent cardiovascular risk factor","volume":"24","author":"Norhammar","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dsx.2024.102992_bib3","first-page":"595","volume":"vol. 30","author":"Rubler","year":"1972"},{"key":"10.1016\/j.dsx.2024.102992_bib4","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2024.102992_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01669","article-title":"Diabetes and arrhythmias: pathophysiology, mechanisms and therapeutic outcomes","volume":"9","author":"Grisanti","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.dsx.2024.102992_bib7","article-title":"The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy","author":"Wasserstrum","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2024.102992_bib8","first-page":"64","volume":"vol. 19","author":"Wang","year":"2020"},{"key":"10.1016\/j.dsx.2024.102992_bib9","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2024.102992_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.hrthm.2018.12.017","article-title":"Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy","volume":"16","author":"S","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.dsx.2024.102992_bib11","first-page":"1186","volume":"vol. 43","author":"Wang","year":"2020"},{"key":"10.1016\/j.dsx.2024.102992_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"vol. 18","author":"Rm","year":"2005","journal-title":"J Am Soci Echocardiograph Offic Publ Am Soci Echocardiograph"},{"key":"10.1016\/j.dsx.2024.102992_bib13","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a Report of the American college of cardiology\/American heart association task force on clinical practice guidelines and the heart rhythm society","volume":"67","author":"Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/dom.13512","article-title":"Atrial fibrillation and type 2 diabetes: prevalence, etiology, pathophysiology and effect of anti-diabetic therapies","volume":"21","author":"Bell","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2024.102992_bib15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2298\/VSP150303219S","article-title":"The influence of type 2 diabetes mellitus on the frequency and complexity of ventricular arrhythmias and heart rate variability in patients after myocardial infarction","volume":"73","author":"Stoickov","year":"2016","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.dsx.2024.102992_bib16","first-page":"H1328","volume":"vol. 317","author":"Jungen","year":"2019"},{"key":"10.1016\/j.dsx.2024.102992_bib17","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2017.08.032","article-title":"Prediction of mid-term outcomes in adult obstructive hypertrophic cardiomyopathy after surgical ventricular septum myectomy","volume":"70","author":"Tang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib18","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2024.102992_bib19","first-page":"2493","volume":"vol. 73","author":"Ariga","year":"2019"},{"key":"10.1016\/j.dsx.2024.102992_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.dsx.2024.102992_bib21","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2019.02.065","article-title":"Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias","volume":"73","author":"Ariga","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCRESAHA.110.221911","article-title":"Reactive oxygen species-activated Ca\/calmodulin kinase II\u03b4 is required for late I(Na) augmentation leading to cellular Na and Ca overload","volume":"108","author":"Wagner","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.dsx.2024.102992_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.redox.2016.08.015","article-title":"Redox signaling in cardiovascular pathophysiology: a focus on hydrogen peroxide and vascular smooth muscle cells","volume":"9","author":"Byon","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.dsx.2024.102992_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib25","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/europace\/euz118","article-title":"A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy","volume":"21","author":"Norrish","year":"2019","journal-title":"Europace Europ Pacing, Arrhythmias, and Cardiac Electrophysiol. J Working Groups Cardiac Pacing, Arrhythmias, And Cardiac Cellular Electrophysiol Europ Soci Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2011.12.063","article-title":"Nonsustained ventricular tachycardia","volume":"60","author":"Katritsis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2024.102992_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402124000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T17:10:17Z","timestamp":1716052217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402124000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1871402124000535"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2024.102992","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of type 2 diabetes on cardiac arrhythmias in patients with obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2024.102992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd on behalf of Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC).","name":"copyright","label":"Copyright"}],"article-number":"102992"}}